Skip to content
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
Home
Careers with Us
Products
Member Center
Shop
Cart
Contact Us
฿
0.00
0
Cart
สมัครสมาชิก
เข้าสู่ระบบ
News
The Group’s in-licensed product Adasuve® (Loxapine for Inhalation) obtained Drug Registration Certificate
December 4, 2023
Wen Guohui, Deputy Secretary of the CPC Guangzhou Municipal Committee and Mayor of Guangzhou visited Zhaoke Pharmaceutical (Guangzhou) Ltd.
September 24, 2019
Zhaoke-Hefei was honoured with the award of “Anhui Provincial High-End Brand Cultivation Demonstration Enterprise in Manufacturing Industry”
September 3, 2021
Azilsartan Tablets won the “Guangdong Prominent High-tech Products” award
April 2, 2024
⟨ Life and Health China Tour 2025 — Henan Province⟩ Treprostinil Injection (芮旎爾®) Launching Ceremony cum Pulmonary Hypertension Summit Forum
May 29, 2025
Lee’s Pharm honored with “Most Popular (ESG) Enterprise Award” in 1st GBA Excellent ESG Enterprise Election
July 4, 2023
Nadroparin Calcium Injection won the bid in China’s new round of drug bulk-buying program
April 13, 2023
Media Interview by Southern Finance Omnimedia Group —— Nansha Plan: Driving R&D and Creating new opportunities for pharmaceutical industry
November 16, 2022
A Recap of 2025 The 2nd Sino-European Brain-Heart Alliance Academic Conference in Shanghai
July 11, 2025
Zhaoke Ophthalmology and Nevakar Entered Into A License Agreement for NVK-002 — Introducing The Eye Treatment For Slowing The Progression of Myopia in Children in Greater China, SEA and South Korea Markets
October 20, 2020
Lee’s flagship product Ferplex® was elected as “2022 Most Valuable Product in Partnership for Drug Store Chain in China”
July 16, 2022
Dr. LI Xiaoyi, Founder of Lee’s Pharm, was interviewed by Guangdong New Focus program
July 11, 2023
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Next
English
Thai
English
✕